Acacia Research Corporation

The CombiMatrix group has developed a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications, from DNA synthesis/diagnostics to immunochemical detection 
 

News

CyGenics' Subsidiary Signs Distribution Agreement with CombiMatrix

🕔11/30/2005 9:13:49 AM 4536

Leading cell therapy company CyGenics Limited (ASX: CYN) announced today that its wholly-owned subsidiary, Cell Sciences Ltd, has entered into a non-exclusive distribution agreement with CombiMatrix group of Acacia Research Corporation (Nasdaq: CBMX:ACTG), to distribute CombiMatrix products and services in Singapore.

Read Full Article
###

1,346 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 17) (Since Published: 1346) 

Company Data